secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2023-12-21T23:59:59+00:00
Accession:  0001193805-23-001637
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunic extends CEO, CMO, CSO contracts through Dec 2026 with revised compensation
--------------------------------------------------------------------------------

- CEO Daniel Vitt: annual salary EUR 565,653, target bonus up to EUR 311,573, term through Dec 31, 2026.
- CMO Andreas Muehler: EUR 231,825 salary (AG) plus $250,000 (Inc.) salary, 50% time to each, term through 2026.
- CSO Hella Kohlhof: annual salary EUR 403,375, target bonus up to EUR 161,350, term through Dec 31, 2026.
- All three got accelerated stock option vesting on termination and a one-year post-termination exercise period.
- New contracts effective Jan 1, 2024, replacing prior agreements; Muehler also signed a separate U.S. employment agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380523001637/0001193805-23-001637-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380523001637/e619130_8k-immunic.htm
  HTML page:      https://secwatch.observer/filing/0001193805-23-001637

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer